AMGN.O,Study raises concerns over Servier, Amgen heart drug BARCELONA, Aug 31 A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year. ~Early data suggest Sanofi, Regeneron drug may halve heart risk * Good news for new PCSK9 drug class but needs confirmation ~
REGN.O,Early data suggest Sanofi, Regeneron drug may halve heart risk * Good news for new PCSK9 drug class but needs confirmation ~
